Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Wendy Onstenk, Anieta M. Sieuwerts, Bianca Mostert, Zarina Lalmahomed, Joan B. Bolt-de Vries, Anne van Galen, Marcel Smid, Jaco Kraan, Mai Van, Vanja de Weerd, Raquel RamÃrez-Moreno, Katharina Biermann, Cornelis Verhoef, Dirk J. Grünhagen, Jan N.M. IJzermans, Jan W. Gratama, John W.M. Martens, John A. Foekens, Stefan Sleijfer
Published Jun 20, 2016 · Vol. 7, No. 37 · pp. 59058-59069
Ramadhan B. Matondo, Mathilda J.M. Toussaint, Klaas M. Govaert, Luciel D. van Vuuren, Sathidpak Nantasanti, Maarten W. Nijkamp, Shusil K. Pandit, Peter C.J. Tooten, Mirjam H. Koster, Kaylee Holleman, Arend Schot, Guoqiang Gu, Bart Spee, Tania Roskams, Inne Borel Rinkes, Baukje Schotanus, Onno Kranenburg, Alain de Bruin
Published Jun 13, 2016 · Vol. 7, No. 34 · pp. 54662-54675
